Follow Us TR

News Details

Amneal Launches Generic Fluphenazine Following ANDA Approval by FDA

About Amneal Pharmaceuticals, Inc. Class A
  • NYSE: $AMRX
  • Notified: $4.76
  • 08:01 EDT

Price Chart